Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Early clinical data discussed for the HIV integrase inhibitor S-1360

July 10, 2002

SSR-182289: novel oral thrombin inhibitor with high potency and selectivity

July 10, 2002

Effective and safe new antithrombotic presented by Pfizer at IUPHAR 2002

July 10, 2002

Bladder-selective antimuscarinic agent from Roche in development for overactive bladder

July 10, 2002

Inspire presents melatonin analogues with IOP-reducing properties

July 10, 2002

NR2B-selective NMDA antagonists for the treatment of pain syndromes

July 10, 2002

Carrageenan-based microbicide PC-710 described at AIDS conference

July 10, 2002

Breakthrough AIDS treatment ready for phase II clinical trials

July 10, 2002

Colesevelam improves LDL particle size distribution in moderate hypercholesterolemia

July 10, 2002

Atazanavir shows a better lipid profile than nelfinavir in HIV-infected patients

July 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...